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ABSTRACT  
Scope: Urolithins (Uro) are ellagic acid (EA)-derived metabolites produced by gut microbes. 
There is a growing interest in the biological activities of Uro. Our aim was to evaluate the 
impacts of Uro on regulating triglyceride (TG) accumulation using cultures of primary human 
adipocytes and hepatoma Huh7 cells. 
Methods and Results: UroA, B, C, D, and iso-UroA, were used to determine the effect of Uro 
on adipogenesis and lipogenesis. Individual Uro (30 M) were added to human adipogenic 
stem cells (hASCs) during differentiation. UroA, C and D, but not iso-UroA and UroB, 
significantly inhibited new fat cell formation by decreasing TG accumulation and adipogenic 
protein and gene expressions. The regulation of TG synthesis by Uro was investigated via 
metabolic chasing with radiolabeled precursors. UroA, C, and D attenuated TG 
accumulation, while increasing the FA oxidation in adipocytes and hepatoma Huh7 cells. 
Furthermore, UroC, D and A promoted the phosphorylation of AMP-activated protein kinase 
(AMPK), suggesting that Uro may alter energy-sensing metabolic pathways in primary 
human adipocytes.  
Conclusions: Taken together, our results demonstrated that UroA, C, and D, but not isoUroA 
and UroB, reduce TG accumulation and increase FA oxidation in adipocytes as well as 
hepatocytes.  
GRAPHICAL ABSTRACT 
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Ellagic acid is a polyphenolic compound ubiquitously founds in berries and pomegranate. Ellagic is 
metabolized into urolithins (Uro) by gut microbes. In this study, we investigated the impact of 
different species of Uro on lipid metabolism by incubating the individual urolithins in human cultures 
of adipocytes and hepatocytes. We identified that UroA, B and D, but not isoUroA and UroB, exert 
distinctive lipid-lowering effects by inhibiting adipocyte differentiation, lipogenesis and by promoting 
beta-oxidation.   
 
1 Introduction 
Ellagitannins (ETs) and ellagic acid (EA) derivatives are naturally occurring 
polyphenols found in pomegranate, berries, and nuts. It has been reported that EA exerts 
various health benefits including free radical scavenger activity and anti-proliferative effects 
in various types of cancer in vivo and in vitro [1-3]. There is a substantial body of evidence 
that supplementation with pure EA alone or consumption of EA-enriched fruits and nuts 
attenuates body fat mass and liver lipids [4-6], suggesting that EA possesses lipid-lowering 
characteristics. Supporting this, our group has recently reported that EA reduces 
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adipogenesis through the inhibition of co-activator arginine methyltransferase 1 (CARM1) in 
primary human adipogenic stem cells (hASCs) [7], alters lipid mechanisms both in human 
adipocytes and hepatocytes [8], and normalizes HF-diet mediated obesity and metabolic 
dysfunction [6, 8].  
Likewise to many other health-promoting polyphenolic compounds, low 
bioavailability of EA remains paradoxical. Oral administration of pure EA or EA-containing 
products in both rodents and humans showed that ~ 1 M of EA can be found in plasma or 
tissues [9, 10]. This is attributed to the fact that EA undergoes extensive metabolic 
transformation prior to absorption [11]. In the intestinal lumen, EA is extensively 
metabolized by gut microbes producing a series of metabolites called urolithins (Uro). Uro 
are characterized by a common 6H-dibenzo[b,d]-pyran-6-one nucleus and a decreasing 
number of phenolic hydroxyl groups (UroD UroC UroA or iso-UroA UroB) (Fig. 1A) 
[12]. Among Uro species, UroA is the major metabolite observed in humans while Iso-UroA 
and UroB conjugates are also observed in some, but not all, humans [12, 13]. As the result 
of microbial actions, EA is converted into bioavailable Uro which can reach significant 
concentrations in plasma and tissues [12, 14-16]. 
Recently, several studies have demonstrated that Uro have metabolic characteristics 
of EA showing anti-inflammatory [17], anti-cancer [18, 19], anti-glycative [20] and anti-
oxidant [21] properties. However, it is largely unknown if Uro have TG-lowering effects by 
altering lipid metabolism. To address this issue, we investigated the effects of individual Uro 
on lipid metabolism in human adipocytes and confirmed augmented fatty acid (FA) 
oxidation in human hepatoma Huh7 cells. Here, we are the first to report that Uro (30 M) 
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possess biological activities to downregulate adipogenesis and lipogenesis similar to EA in 
human adipocytes. We also demonstrated that Uro alter lipid metabolism via AMPK 
activation.  
  
 
2 Materials and methods 
2.1 Chemical reagents 
 All cell culture supplies were purchased from Fisher Scientific. Fetal bovine serum 
(FBS) and penicillin-streptomycin were purchased from Cellgro Mediatech, Inc. (Herndon, 
VA). Rosiglitazone (BRL49653) was purchased from Cayman Chemical (Ann Arbor, MI). EA 
was purchased from Sigma-Aldrich (St. Louis, MO). UroA, B, C, D and iso-UroA were 
obtained as described elsewhere [22]. All other chemicals and reagents were purchased 
from Sigma Chemical Co (St. Louis, MO), unless otherwise stated. 
 
2.2 Cell culture 
All protocols and procedures were approved by the Institutional Review Board at the 
University of Nebraska-Lincoln. For isolation of human adipogenic stem cells (hASCs), 
abdominal adipose tissue was obtained from females with a body mass index (BMI) of ~30 
during liposuction or abdominal plastic surgeries. Isolation of hASCs and differentiation of 
adipocytes was conducted as we described previously [7, 8]. Each independent experiment 
was repeated at least three times using a pool of hASCs from three or four human subjects 
to avoid individual variation. Huh7 cells were maintained in Dulbecco’s modification of 
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Eagle’s medium (DMEM) containing 1% L-glutamine, 10% fetal bovine serum, 100 units/ml 
penicillin, 100  g/ml streptomycin in 5% CO2 at 37°C. The medium was changed every 3 
days. 
 
2.3 Cell viability assay 
 The cytotoxic effects of Uro and EA were determined using the XTT Cell Viability Kit 
(Cell Signaling Technology, Danvers, MA) according to the manufacturer’s protocol. Briefly, 
undifferentiated hASCs, fully differentiated hASCs, and Huh7 cells were cultured in 96-well 
plates using a seeding density of ~20,000 cells per well. Cells were incubated with either 
dimethyl sulfoxide (DMSO) or increasing concentrations of Uro and EA for 24 hours (Fig. 2, 
5). Culture medium was then replaced with fresh medium containing XTT solution for 3 
hours at 37℃ before measurement of OD 450 nm using a Synergy™ H1 hybrid plate reader 
(BioTek, Winooski, VT). 
 
2.4 Lipid accumulation  
To measure the lipid accumulation in human adipocytes, cells were fixed with 10% 
formalin and stained with Oil Red O (ORO). Bright field images were taken by EVOS® XL 
microscope (AMG), or ORO dye was extracted by isopropanol to quantify relative TG 
accumulation (at OD 500 nm). 
 
2.5 [14C]-oleic acid (OA) and [3H]-acetate incorporation into FA and TG 
The measurement of TG esterification rate and de novo lipid synthesis in cultures of 
mature adipocytes or human hepatoma Huh7 cells was conducted as described previously 
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[8]. Briefly, cells were incubated with serum-free low glucose (1,000 mg/L d-(+)-glucose) 
overnight before the experiment. [14C]-OA (final concentration of 0.5 μCi/mL, Perkin Elmer) 
and [3H]-acetate (final concentration of 0.5 μCi/mL, Perkin Elmer) were mixed with 
conditioned media or sodium oleate (Sigma)-Bovine Serum Albumin (BSA, fatty acid free, 
Sigma) complex, then added to cells for 3 hours. After 3 hours incubation with [14C]-OA and 
[3H]-acetate, medium (containing unincorporated isotope) was removed by washing with 
phosphate-buffered saline (PBS). Cellular lipids were extracted using the Bligh and Dyer 
method [23]. Next, thin layer chromatography was performed to fractionate FA and TG, and 
the [14C] and [3H] radioactivity was measured by liquid scintillation counting (Tri-Carb 
2000TR, Packard). Radioactivity was normalized by protein concentration quantified by 
bicinchoninic acid (BCA) colorimetric assay (Pierce, Rockford, IL).  
 
2.6 Fatty acid oxidation rate using [3H]-OA 
To measure the FA oxidation rate in cultures of mature adipocytes or human 
hepatoma Huh7 cells, we followed previously published methods [24]. Briefly, cells were 
incubated with serum-free low glucose (1,000 mg/L d-(+)-glucose) before the experiment. 
[3H]-OA (final concentration of 0.5 μCi/mL, Perkin Elmer) was mixed with sodium oleate-BSA 
complex, and then added to cells for 2 hours. [3H] radioactive containing medium was 
harvested, and precipitated using trichloroacetic acid (TCA) solution. After precipitation, 6N 
NaOH was added to reach a final concentration of 0.8-1.0N, resulting in an alkaline 
supernatant. Next, supernatant was put through columns filled with Dowex™ ion-exchange 
resin (ACROS Organics™) to capture [3H]-H2O. Finally, radioactivity was measured by liquid 
scintillation counting. 
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2.7 qPCR  
Gene-specific primers for qPCR were obtained from Integrated DNA Technologies 
(Chicago, IL). Total RNA was isolated using TRIzol® reagent (Invitrogen). To remove any 
potential genomic DNA contamination, mRNA was treated with DNase (Mediatech), and 2 
μg of mRNA was converted into cDNA in a total volume of 20 l (iScript™ cDNA Synthesis 
Kit, Bio-Rad). Gene expression was determined by real-time qPCR (ABI7300, Applied 
Biosystems), and relative gene expression was normalized by 36B4 (primer sequences 
available in Supplemental Table 1).  
 
2.8 Western blot analysis 
To prepare total cell lysates, monolayers of hASC cultures and fully differentiated 
adipocytes were scraped with ice cold radioimmune precipitation assay (RIPA) buffer 
(Thermo Scientific) containing protease inhibitors (Sigma) and phosphatase inhibitors (2 mM 
Na3VO4, 20 mM β-glycerophosphate and 10 mM NaF). Proteins were fractionated using 8 or 
10% SDS-PAGE, transferred to PVDF membranes, and incubated with the relevant 
antibodies. Chemiluminescence from ECL (Western Lightning) solution was detected using a 
FluorChem E Imaging System (Cell Biosciences). Polyclonal or monoclonal antibodies 
targeting phospho- AMP-activated protein kinase (AMPK) (Ser473, #4060), total AMPK 
(#9279), CCAAT/enhancer binding protein  (C/EBP (#2295), fatty acid synthase (Fas) 
(#3180), and β-actin (#4967) were purchased from Cell Signaling Technology. The mouse 
monoclonal antibodies for fatty acid binding protein 4 (aP2) (sc-271529) and PPAR (sc-
7273) were purchased from Santa Cruz Biotechnology (Dallas, TX).  
www.mnf-journal.com Page 9 Molecular Nutrition & Food Research 
 
 
This article is protected by copyright. All rights reserved. 
9 
  
 
2.9 Statistical analysis 
Results are presented as means ± SEM. The data were statistically analyzed using 
one-way ANOVA with Tukey’s multiple comparison tests. All analyses were performed with 
GraphPad Prism 5 (Version 5.04).   
 
 
3 Results 
Urolithins do not affect the viability of primary human adipogenic stem cells (hASCs) at 
concentrations of 0-30 M  
Currently, it is unknown whether Uro affect the cell viability of human adipocytes. To 
address this question, cytotoxic effects of individual Uro were determined both in 
undifferentiated hASCs and fully differentiated adipocytes. UroA, B, C, D, iso-UroA and EA 
were incubated with either hASCs or mature adipocytes for 24 hours before XTT assay. 
Similar to EA, Uro treatment slightly affected cell bioavailability (~80%) but no specific 
cytotoxic effects were observed in up to 30 M concentrations (Fig. 1B-G). Based on these 
results, for the remaining experiments we used the 30 M of Uro in order to augment the 
potential action but without causing cellular damage.  
 
3.2 Urolithins inhibit adipogenesis in hASCs 
We previously demonstrated that EA suppressed adipogenic differentiation in hASCs 
[7, 8]. To determine whether Uro were able to inhibit adipogenesis, 30 M individual Uro 
was added to hASCs during differentiation (Fig. 2A). The presence of Uro, but not iso-UroA, 
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caused a significant reduction of TG accumulation measured by ORO staining (Fig. 2A, B). 
The rank order of anti-adipogenic potential was UroA, C, D >> UroB > iso-UroA as assessed 
by TG accumulation using ORO staining. To further confirm the anti-adipogenic effects of 
Uro, adipogenic gene and protein expression levels were determined by qPCR and Western 
blot. Consistent with reduced TG accumulation, Uro treatment, except for iso-UroA, 
significantly suppressed adipogenic gene expression including PPAR and Fas (Fig. 2C). 
Adipogenic protein expression including aP2, Fas, PPAR, and C/EBP were also dramatically 
reduced in cultures treated with UroC and D and to a lesser magnitude with UroA (Fig. 2D). 
To gain insight into whether Uro alter epigenetic marks similar to their parent compound EA 
[7], histone 3 arginine 17 methylation (H3R17me2), and histone acetylation (AcH3) levels 
were examined. Interestingly, only UroC incubation, but no other Uro treatment, markedly 
suppressed the epigenetic markers (Supplemental Fig. 1).  
Several phytochemicals are known to inhibit adipogenesis through the mechanism 
related to AMPK activation [25-28]. AMPK is a major energy-sensor triggering a variety of 
catabolic processes and suppressing anabolic pathways simultaneously [29]. Treatment with 
EA increased AMPK phosphorylation dose-dependently (Fig. 2E). To further identify whether 
Uro are also able to regulate AMPK activation, we examined phosphorylated and total 
AMPK levels. Interestingly, UroA, C, and D increased phosphorylated AMPK levels (Fig. 2F), 
which is consistent with the trend of the anti-adipogenic role of Uro. 
 
3.3 Urolithins attenuate lipid accumulation in cultures of human adipocytes  
Next, we asked whether Uro could antagonize adipocyte hypertrophy. To examine 
this, fully differentiated cultures of human adipocytes were exposed to Uro for seven days 
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based on the experimental design (Fig. 3A, upper). Exposure to 30 M Uro for seven days 
caused a significant reduction of TG accumulation, but not UroB and iso-UroA, as measured 
by ORO staining (Fig. 3A, below). To test whether the reduction of TG accumulation was 
aligned with lipogenic transcriptional inhibition, we measured mRNA expressions. Uro 
treatment (A, C, and D) decreased lipogenic-specific gene expression including PPAR, Fas, 
adipose triglyceride lipase (ATGL) and steroyl-CoA desaturase-1 (SCD-1) compared to vehicle 
control (Fig. 3B). UroC and D are potent EA-derived metabolites in upregulating AMPK 
activation in fully differentiated adipocytes (Fig. 3C).  
 
3.4 Urolithins regulate lipid metabolisms in cultures of human adipocytes 
We then investigated whether lipid-lowering effects of Uro are due to an alteration 
of lipogenic pathways. Fully differentiated adipocytes were incubated with radioactive 
precursors of [3H]-acetate and [14C]-OA to measure their conversion into [3H]-TG (de novo 
synthesis of TG) and [14C]-TG (esterification of TG). The conversion of [3H]-acetate into [3H]-
TG was significantly dampened in UroA and UroD treated adipocytes (Fig. 4A). Consistently, 
UroA and D incubation was associated with a significant decrease of conversion of [14C]-OA 
into [14C]-TG, indicating a decrease of TG esterification by UroA and D (Fig. 4B). To 
determine whether FA oxidation is involved in lipid-lowering effects of Uro, we measured FA 
oxidation rate in Uro-treated adipocytes. FA oxidation by determining [3H]-H2O release from 
[3H]-OA clearly showed that UroA, C, and D markedly increased FA oxidation, but not in iso-
UroA and UroB treated adipocytes (Fig. 4C). Taken together, these data implicate that the 
inhibition of de novo synthesis of TG and FA esterification are accompanied by 
transcriptional regulation of lipogenic gene expression in Uro-treated human adipocytes.   
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
 Urolithins regulate lipid metabolism in Huh7 cells  
We further examined the effects of Uro on TG esterification, de novo synthesis and 
FA oxidation in human hepatoma Huh7 cells. Prior to analysis of lipid metabolism, we first 
measured the cytotoxic effects of individual Uro in Huh7 cells. The concentrations (0-30 M) 
of UroA, B, C, D, iso-UroA and EA treatment slightly affected cell bioavailability (~80%) but 
no specific cytotoxic effects were observed in up to 30 M concentrations (Fig. 5A). Next, to 
test whether Uro alter the lipogenic pathways, radiolabeled precursors were incubated with 
Huh7 cells, as with human adipocytes. Incorporation of [3H]-acetate into [3H]-FA and [3H]-TG 
were markedly decreased with UroC and D (Fig. 5B and C). Conversion of [14C]-OA into [14C]-
TG was clearly inhibited by UroC treatment (Fig. 5D). FA oxidation rate was increased by 
UroA and C treated Huh7 cells, which was confirmed by [3H]-H2O release from [
3H]-OA (Fig. 
5E).  
 
 
4 Discussion 
Uro are gut microbiota-derived metabolites of EA and ETs. Different types of Uro 
(Fig. 1A) are produced by intestinal microbes, which may reflect the metabolic health status 
of hosts [13]. Although it has long been known that Uro may be critical determinants of the 
effectiveness of EA supplementation, it is largely unknown whether different species of Uro 
possess different biological activities in humans. Recently, a number of studies have 
reported the unique role of Uro species by evaluating their efficacy in various cancer [18, 
30], and inflammatory diseases [17, 31]. One recent study [13] and other unpublished 
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observation correlate a higher prevalence of the metabotype producing iso-UroA and UroB 
in overweight and obese individuals, while UroA is associated with healthy individuals. 
However, no studies have been conducted to determine the function of individual Uro in 
human obesity. The present study was specifically designed to assess the role of individual 
Uro species in manipulating lipid metabolism using primary human adipocytes. Here we 
demonstrated that UroA, C and D are effective in attenuating TG accumulation and 
increasing FA oxidation through AMPK-dependent mechanisms in primary human 
adipocytes as well as in Huh7 cells. These results may provide a novel insight into a 
‘structure and function’ relationship among Uro, which may lead to a unique therapeutic 
design to control adiposity.   
An accumulating body of evidence suggests that the gut microbial community affects 
the host’s energy homeostasis by altering energy metabolism [32-34]. To corroborate this 
concept, production of different Uro may comprise a part of the mechanism in which gut 
microbes regulate the host’s energy metabolism. In other words, metabolically healthy 
subjects may possess microbiota that are able to generate mainly active Uro such as UroA 
(i.e. subjects belonging to the so-called ‘metabotype A’ [13]). In contrast, metabolically 
unhealthy humans may have bacterial communities producing UroA but also other less 
active urolithins such as iso-UroA and UroB (i.e., subjects with ‘metabotype B’ [13]). García-
Villalba et al. reported that there were compositional differences in the gut microbiome 
between human subjects who produce UroA (effective Uro) and who produce iso-UroA and 
B (less active Uro) [11, 35]. Also, subjects who have a higher risk of chronic illness produce 
iso-UroA and UroB [13], the two inactive EA metabolites in our experimental setting (Fig. 2-
4). Recently, Gordonibacter urolithinfaciens sp. nov. has been identified as a novel bacterial 
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species responsible for converting EA into UroM5 and UroC [36]. This bacterium belongs to 
the family Coriobacteriaceae a family that is associated with benefits in obesity [37]. Since 
the bacterial phylum that specifically transform EA or its intermediate metabolites into UroA 
vs. iso-UroA/UroB have not yet been identified, it could be of interest for future studies.  
Numerous studies in animals and humans have demonstrated that free EA can be 
found in no more than 100 nM concentrations after oral administration of EA or ET-
containing foods [9, 10]. The low bioavailability of EA is largely due to limited solubility and 
its rapid metabolism into Uro by the gut microbiome [10]. As a metabolic consequence, Uro 
can reach relevant concentrations in the blood stream and human colon microenvironment 
[12, 14]. Although Uro might not be accumulated in metabolic tissues, i.e., adipose tissue, 
liver or muscle, a few reports have shown that Uro are able to circulate enterohepatically 
[38]. In terms of cytotoxicity, 50-150 M of Uro have exhibited anti-cancer properties by 
inhibiting cell proliferation and cell cycle progression in various carcinoma cell lines [18, 39]. 
In this study, we first assessed the cytotoxicity of 30 M concentration in hASCs as well as 
differentiated cultures of adipocytes. However, Uro treatment does not seem to affect cell 
viability in non-carcinogenic cells [31], implying that Uro might induce apoptosis in 
malignant tumor cells but not in mitogenically quiescent cells. Consistently, our results 
showed that 30 M Uro treatments showed no sign of cytotoxicity in time frames of both 
early- and terminal-stages of adipogenesis. The anti-adipogenic and anti-lipogenic effects of 
Uro in our study were not due to the apoptotic property of Uro (Fig. 1B-G). Thus, we 
regarded 30 M of Uro as a non-toxic concentration to assess potency of individual Uro in 
regulating lipid metabolism in human adipocytes. This concentration is selected to be 
comparable to our previous studies showing that 10 M of EA treatment lowers TG 
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deposition in the same cells, i.e., primary human adipocytes and human hepatoma cell lines 
[8]. Despite that detectable plasma level of Uro in humans is obviously lesser than 30 M, 
our assay conditions using 30 M of Uro is rationed based on the facts that 1) treatment of 
high dose of polyphenolics are valid when we characterize the biological significance of 
polyphenolic molecules (such as resveratrol) using in vitro systems, and 2)  in the context of 
urolithins, the reported systemic concentrations of urolithins can reach up to micro molar 
levels [14]. These concentrations can be much higher in the gut [16] and also in the bile [38]. 
In our study, 30 M of Uro treatment in adipocytes was associated with at least three 
metabolic outcomes: 1) attenuating adipogenesis, 2) inhibiting TG accumulation, and 3) 
increasing AMPK activation. 
The major distinctive metabolic consequences that we immediately noticed was that 
Uro differentially impacted adipogenesis in hASCs. UroA, C and D treatment, but not iso-
UroA or UroB, interfered with adipogenic differentiation (Fig. 2). Recently, estrogen 
receptor  (ER) has been proposed as a negative regulator of adipocyte development in 
preadipocytes [40]. Interestingly, Larrosa et al. showed that UroA possesses higher ER 
binding affinity than UroB in breast cancer cells suggesting that UroA plays a role as a 
phytoestrogen (ER binding affinity of UroA:  > . In terms of structural differences, 
EA, UroA, C and D have common hydroxyl position at number 8 carbon (-OH at C8) 
compared to iso-UroA or UroB. González-Sarrías et al. also proposed that phase II phenolic 
enzymatic activities are crucially affected by reactive moieties such as hydroxyl groups [18]. 
This interpretation aligns with our results showing that the absence of -OH moiety at C8 
position of Uro, due to isomerism (iso-UroA) or metabolic loss (UroB) is inversely correlated 
with the ability to downregulate adipogenic differentiation. Thus, it may also be reasonable 
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to assume that -OH moiety at C8 position might affect binding affinity to ER. Further studies 
are necessary to validate the aforementioned structure-function relationship in adipogenic 
differentiation. The other possible mechanism of Uro’s anti-adipogenic effect could be 
explained by its ability to alter epigenetic marks. We have previously shown that EA 
modified histone methyltransferase (CARM1) enzyme activities during adipogenesis [7]. 
Consistently, we were able to observe that UroC downregulated histone arginine 17 
methylation during adipogenesis (Supplemental Fig. 1). UroC was also reported to reduce 
TNF-induced inflammation through inhibition of histone acetyltransferase (HAT) activity in 
the monocyte cell [42]. At this point, we speculate UroC may have stronger DNA binding 
affinity comparable to EA [43, 44] than the other Uro intermediates, conferring ability to 
edit epigenetic codes such as histone methylation and/or acetylation. Collectively, 
differential regulation of adipogenesis by Uro likely originates from their structural 
difference of Uro. Future studies are required to scrutinize the metabolic contribution of C8 
hydroxyl moiety of Uro to ER binding affinity, CARM1 activity, and AMPK activation.   
Subsequently, we examined the potential role of Uro in regulating lipid metabolism 
in fully differentiated adipocytes and hepatoma Huh7 cells. Previously, we showed that EA 
modulates global lipid metabolism by attenuating TG accumulation in both adipocytes and 
hepatocytes [8]. This TG-lowering effect seems to be conserved in mammalian cells [8] and 
even in yeasts (data not shown). In this current research setting, we found that Uro 
effectively reduced de novo synthesis and TG esterification and enhanced FA oxidation in 
adipocytes (Fig. 3, 4). These data revealed that EA apparently gradually lost its ability to 
downregulate lipid accumulation while EA is successively metabolized by gut microbes until 
its conversion to the least effective UroB. Therefore, the potency of Uro in regulating TG 
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metabolism could be ranked as earlier metabolites (UroC and D) > intermediate metabolite 
(UroA) > later metabolite (UroB). Agreeing to the fact that EA shows a global impact in 
lowering lipids in various cells, Uro were also effective in attenuating TG accumulation in 
Huh7 cells (Fig. 5). The simultaneous lipid-lowering action in both adipocytes and 
hepatocytes is one of the ultimate goals for weight loss as dietary intervention agents. To 
accomplish this goal, upregulation of FA oxidation is critical; otherwise the failure of FA 
accumulation in adipose tissue triggers lipotoxicity and hepatic steatosis. It is interesting 
that UroC was more potent in modulating TG accumulation than UroD in hepatocytes. More 
noticeably, UroA, C and D significantly elevated FA oxidation ([3H]-OA[3H]-H2O) in 
hepatocytes, satisfying the criteria for effective dietary supplementation to mitigate lipid 
accumulation both in adipocytes and hepatocytes. Further studies should be conducted to 
determine the efficacy of UroC, D and A in vivo.   
Lastly, we have found AMPK activation could be a link mediating anti-adipogenic and anti-
lipogenic effects of Uro. AMPK is an energy sensor that shuts down anabolic pathways [45]. 
Phosphorylation of AMPK inhibits transcriptional activation for adipogenesis, TG synthesis, 
and FA oxidation [46]. Here, we showed EA promotes AMPK activation during adipogenesis 
of hASC (Fig. 2E); Wang et al. also showed the implication of AMPK activation by EA in 3T3-
L1 cells [47]. Consistently, our results showed that upregulation of AMPK phosphorylation 
by UroA, C, and D attenuated: i) adipogenesis (Fig. 2); ii) de novo lipogenesis (gene 
expressions and metabolic conversion of radiolabeled precursors) and TG esterification (Fig. 
3, 4, 5); and iii) FA oxidation (Fig. 4, 5). Consistently, the recent animal study showed that 
punicalagin (ET)-enriched pomegranate consumption prevents obesity associated-cardiac 
metabolic disorders through AMPK activation [48]. The regulation of AMPK by the structural 
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specificity of EA and Uro will be of interest for future study to further elucidate the ultimate 
role of EA in regulating lipid metabolism. 
In our study, we revealed the previously unknown function of Uro, gut metabolites 
of EA, as potential regulators of lipid metabolism in adipocytes. We also compared whether 
individual Uro could exert a differential impact on lipogenesis and FA oxidation in 
adipocytes and hepatocytes. We identified that UroA, C, and D are more plausible to reduce 
TG accumulation, but not iso-UroA and UroB. Whether the differential impact of Uro in lipid 
metabolism is dictated by structural differences of Uro, and these initial findings in vitro will 
be confirmed in vivo, must await future studies. Using high dose of Uro (30 M), that may 
not easily attainable in human physiological conditions, is an obvious limitation of this study. 
As a seminal investigation, it was inevitable to simulate the chronic dietary responses using 
the cell-based platform in short term. Studies whether lower-dose Uro with prolonged 
treatment can recapitulate the current results should be confirmed in future studies. In 
addition, following studies should define whether the mode of action from the tentative 
mixtures of Uro (that are pertinent to human physiology) would be additive, synergistic 
and/or counteractive. Nevertheless, we believe that our study sheds new insight into Uro, 
gut metabolites of EA, as new dietary strategies to attenuate adiposity. 
 
SUPPORTING INFORMATION 
mnfr201500796-sup-0001-Supplemental Fig1.docx 
Supplemental Fig. 1. Cultures of hASCs were induced to differentiation (d1) in the presence 
of either DMSO (vehicle control) or 30 M Uro for 10 days. Nuclear extracts from Uro 
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treated hASCs were immunoblotted for histone modification enzyme (H3R17me2, AcH3, 
and PPAR). 
 
mnfr201500796-sup-0002-Supplemental Table1.docx 
Supplemental Table 1. Primer sequences for qPCR 
Gene Forward/Reverse Sequence (5′-3’) 
h36B4 
Forward GAAGGCTGTGGTGCTGATG 
Reverse GTGAGGTCCTCCTTGGTGAA 
hATGL 
Forward CTGACCACCCTCTCCAACAT 
Reverse ACCAGGTACTGGCAGATGCT 
hFas 
Forward GGCAAGCTGAAGGACCTGTCTA 
Reverse AATCTGGGTTGATGCCTCCGT 
hPPAR 
Forward TGCTGTTATGGGTGAAACTCTG 
Reverse TCAAAGGAGTGGGAGTGGTC 
hSCD1 
Forward GGGTGAGGGCTTCCACAACTA 
Reverse CGGCCATGCAATCAATGAA 
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Figure Legends 
Figure 1. Metabolism of EA to produce Uro and the effects of Uro on cell viability in 
primary human adipocytes.  
(A) Microbial enzymatic transformation to produce a series of Uro metabolites from EA. 
Chemical structures of test compounds are shown. Human culture of undifferentiated hASCs 
(open circle) and fully-differentiated adipocytes (closed circle) were treated with 0, 5, 10, 
30M of EA (B) or UroA (C), iso-Uro A (D), UroB (E), UroC (F), and UroD (G) for 24 hours. XTT 
reagent was added 3 hours before measurement of OD 450nm. Data are expressed as a 
percentage of the vehicle control (DMSO). Each data point represents the mean ± S.E.M 
(n=3). 
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Figure 2. Uro, but not iso-UroA, suppressed adipogenesis in hASCs.  
(A, upper) Experimental Scheme: hASCs were seeded the day before differentiation (d0). 
Cultures of hASCs were induced to differentiation (d1*) in the presence of either DMSO 
(vehicle control) or 30 M Uro for 10 days. (A, below) Triglyceride accumulation was 
visualized by Oil Red O staining and representative images from three separate experiments 
are shown. (B) Extracted staining was quantified (OD 500 nm) and relative TG accumulations 
to the DMSO control are shown. (C) Adipogenic gene expression of PPAR, and Fas by qPCR 
(n=5). (D) Adipogenic protein expressions of aP2, Fas, PPAR, and C/EBP by Western blot 
analysis. (E) Culture of hASCs was differentiated for 2 days in the presence or absence of 0, 
4, and 8 M EA. Total cell extracts were immunoblotted with phosphor or total antibodies 
targeting AMPK. (F) Immunoblot of phosphor or total antibodies targeting AMPK in Uro 
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treated hASCs. All values are presented as the mean ±S.E.M. Bars with different letters are 
significantly different by one-way ANOVA. 
 
Figure 3. Uro, but not iso-UroA, suppressed lipogenesis in mature human adipocytes.  
(A, upper) Experimental Scheme: hASCs were seeded the day before differentiation (d0) and 
induced to differentiation (d1*). hASCs were kept differentiated into fully differentiated 
adipocytes until d10. 30 M Uro was added to the fully differentiated human adipocytes 
(d10) and incubated for 7 days. (A, below) Relative TG accumulations quantified by Oil Red 
O. (B) Relative gene expressions levels of PPAR, Fas, ATGL and SCD-1 by qPCR (n=5). (C) 
Cultures of fully differentiated adipocytes were treated with 30 M Uro for 3 days. Total cell 
extracts were immunoblotted with phosphor or total antibodies targeting AMPK. All values 
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are presented as the mean ±S.E.M. Bars with different letters are significantly different by 
one-way ANOVA.   
 
Figure 4. Uro regulated lipid metabolisms in human adipocytes. 
Uro (30 M) was added to the differentiated human adipocytes (d10) and incubated for 3 
days.  
www.mnf-journal.com Page 27 Molecular Nutrition & Food Research 
 
 
This article is protected by copyright. All rights reserved. 
27 
  
(A) Conversion of [3H]-acetate into [3H]-TG. (B) Conversion of [14C]-OA into [14C]-TG. (C) [3H]-
OA into [3H]-H2O. All values are presented as the mean ±S.E.M. (n=6/group) Bars with 
different letters are significantly different by one-way ANOVA.   
 
Figure 5. Uro, but not iso-UroA, regulated lipid mechanisms in human hepatoma Huh7 
cells.  
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(A)Cultures of Huh7 cells were treated with either 10M EA or 30 M UroA, iso-Uro A, 
UroB, UroC, and UroD for 24 hours. XTT reagent was added 3 hours before measurement of 
OD 450nm. Huh7 cells were pre-incubated with Uro (30 M) for 48 hours and 0.4 mM BSA-
OA complex was loaded for 3 hours with radiolabeled precursors ([3H]-acetate, [14C]-OA, 
[3H]-OA). (B) Conversion of [3H]-acetate into [3H]-FA. (C) Conversion of [3H]-acetate into [3H]-
TG. (D) Conversion of [14C]-OA into [14C]-TG. (E) Conversion of [3H]-OA into [3H]-H2O. All 
values are presented as the mean ±S.E.M. (n=6/group for each experiment) Bars with 
different letters are significantly different by one-way ANOVA. 
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